DEFA14A ·Filed Apr 14, 2026

AVNS

AVANOS MEDICAL, INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001104659-26-043093
Proxy solicitation materials
Actionable Insight • Neutral

Traders should monitor for further merger-related disclosures, including revised proxy materials and a rescheduled shareholder vote. The postponement suggests the merger process is active but may require additional regulatory or procedural steps.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
AVNS ▲ +1.26% at T+60d
NEUTRAL call ✓ call won +1.26% · α vs SPY -7.26% · entry $24.63 → $24.94
Entry anchored
Apr 14, 01:58 PM ET
via exchange tick
T+1d
+0.37%
call +0.37% · α -0.41%
$24.72
settled 6mo ago
T+5d
+0.04%
call +0.04% · α -1.35%
$24.64
settled 5mo ago
T+20d
+0.73%
call +0.73% · α -5.56%
$24.81
settled 5mo ago
T+60d
+1.26%
call +1.26% · α -7.26%
$24.94
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Avanos Medical has postponed its 2026 Annual Meeting of Stockholders, originally set for April 21, 2026, due to its pending merger. This filing serves as definitive additional proxy materials disclosing the postponement.

Key Facts

  • Avanos Medical, Inc. (AVNS) has postponed its 2026 Annual Meeting of Stockholders.
  • The meeting was originally scheduled for April 21, 2026, and is being delayed due to a pending merger.
  • This DEFA14A filing is definitive additional materials related to the postponement.
  • The company filed the notice on April 14, 2026.

Financial Impact

No direct financial impact disclosed; postponement is procedural in light of merger.

meeting dategovernance timeline

Risk Factors

  • Merger delays or regulatory hurdles could extend timeline.
  • Integration risks or deal termination could impact shareholder value.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001104659-26-043093
Document: 0001104659-26-043093-index-headers.html0001104659-26-043093
Document: 0001104659-26-043093-index.html0001104659-26-043093
Document: 0001104659-26-043093.txt0001104659-26-043093
7 reports for AVNS
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +1.13%Apr 23, 2026
Filters
Rows
Reports for AVNS — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
25-NSE
NEUTRAL ★ 5/10
$24.99 awaiting T+5awaiting T+5——
Jul 2, 2026
13w ago
8-K / DEFA14A
BULLISH ★ 7/10
$24.93 $24.94▲ +0.04%▼ −0.89%—
Jun 10, 2026
16w ago
DEFM14A
BULLISH ★ 8/10
$24.98 $24.87▼ −0.44%▼ −0.87%—
May 5, 2026
21w ago
DEFA14A
NEUTRAL ★ 5/10
$24.72 $24.73▲ +0.04%▼ −1.09%—
Apr 23, 2026
23w ago
DEFA14A
BULLISH ★ 8/10
$24.71 $24.65▼ −0.24%▼ −1.72%—
Apr 14, 2026
24w ago
DEFA14A
NEUTRAL ★ 4/10
$24.63 $24.64▲ +0.04%▼ −1.35%—
Feb 26, 2026
31w ago
8-K
NEUTRAL ★ 5/10
$14.49 $13.79▼ −4.83%▼ −3.70%—
Showing 7 of 7

US Market Status

Market Closed — Opens Mon (64h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access